MERCEDES ACOSTA: Open Payments
NPI 1083016737 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,161 in 79 payments from 15 companies in 2025. Trend: 2023 $2,523 · 2024 $1,979 · 2025 $2,161
Food & beverage: $2,161
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $437 |
| Madrigal Pharmaceuticals | 8 | $369 |
| Janssen Biotech, Inc. | 14 | $340 |
| Phathom Pharmaceuticals, Inc. | 8 | $307 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $300 |
| GENZYME CORPORATION | 3 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Aimmune Therapeutics, Inc. | 3 | $46 |
| Biocon Biologics Inc | 2 | $45 |
| PFIZER INC. | 2 | $35 |
Products named: REZDIFFRA, TREMFYA, VOQUEZNA, ENTYVIO, SKYRIZI, RINVOQ, DUPIXENT, CREON.
Industry payments across FL — which companies pay providers there.
